InvestorsHub Logo
Followers 16
Posts 1523
Boards Moderated 0
Alias Born 08/09/2011

Re: dcaf7 post# 166

Friday, 12/23/2022 12:21:11 PM

Friday, December 23, 2022 12:21:11 PM

Post# of 567
Keep in mind that people are being treated who are in advanced stages of AML. 239 is working where previously applied treatments did not work. Some people are going to be too close to passing to benefit from any form of treatment. The commentary indicated that 239 was NOT responsible for a patient passing. My contention is that the company still needs to determine the ideal dosage and move forward toward FDA review.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APTO News